Medifast (NYSE:MED) reported its Q1 earnings results on Monday, May 2, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Medifast beat estimated earnings by 0.56%, reporting an EPS of $3.59 versus an estimate of $3.57.
Revenue was up $76.93 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.26 which was followed by a 2.0% drop in the share price the next day.
Here's a look at Medifast's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | 2.65 | 3.08 | 3.31 | 2.73 |
| EPS Actual | 2.91 | 3.56 | 3.96 | 3.46 |
| Revenue Estimate | 375.79M | 403.76M | 358.45M | 278.89M |
| Revenue Actual | 377.83M | 413.39M | 394.19M | 340.67M |
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Guidance
Medifast management provided guidance for FY 2022, expecting earnings between $14.6 and $16.05 per share.
To track all earnings releases for Medifast visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
